These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 27586799)

  • 1. The importance of the type I interferon system in autoimmunity.
    Rönnblom L
    Clin Exp Rheumatol; 2016; 34(4 Suppl 98):21-4. PubMed ID: 27586799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cause and consequences of the activated type I interferon system in SLE.
    Eloranta ML; Rönnblom L
    J Mol Med (Berl); 2016 Oct; 94(10):1103-1110. PubMed ID: 27094810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting of type I interferon in systemic autoimmune diseases.
    Crow MK; Olferiev M; Kirou KA
    Transl Res; 2015 Feb; 165(2):296-305. PubMed ID: 25468480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The important roles of type I interferon and interferon-inducible genes in systemic lupus erythematosus.
    Luo S; Wang Y; Zhao M; Lu Q
    Int Immunopharmacol; 2016 Nov; 40():542-549. PubMed ID: 27769023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The type I interferon system in the development of lupus.
    Rönnblom L; Alm GV; Eloranta ML
    Semin Immunol; 2011 Apr; 23(2):113-21. PubMed ID: 21292501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Signaling Pathways of Type I and Type III Interferons and Targeted Therapies in Systemic Lupus Erythematosus.
    Chyuan IT; Tzeng HT; Chen JY
    Cells; 2019 Aug; 8(9):. PubMed ID: 31450787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Type I interferons in systemic autoimmunity.
    Sozzani S; Bosisio D; Scarsi M; Tincani A
    Autoimmunity; 2010 Apr; 43(3):196-203. PubMed ID: 20298124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endogenous type I interferon inducers in autoimmune diseases.
    Finke D; Eloranta ML; Rönnblom L
    Autoimmunity; 2009 May; 42(4):349-52. PubMed ID: 19811298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Type I interferon antagonists in clinical development for lupus.
    Paredes JL; Niewold TB
    Expert Opin Investig Drugs; 2020 Sep; 29(9):1025-1041. PubMed ID: 32700979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The type I interferon system in the etiopathogenesis of autoimmune diseases.
    Rönnblom L
    Ups J Med Sci; 2011 Nov; 116(4):227-37. PubMed ID: 22066971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The interferon signature in autoimmune diseases.
    Rönnblom L; Eloranta ML
    Curr Opin Rheumatol; 2013 Mar; 25(2):248-53. PubMed ID: 23249830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic Lupus Erythematosus--A Disease with A Dysregulated Type I Interferon System.
    Hagberg N; Rönnblom L
    Scand J Immunol; 2015 Sep; 82(3):199-207. PubMed ID: 26099519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Type I Interferon and the Spectrum of Susceptibility to Viral Infection and Autoimmune Disease: A Shared Genomic Signature.
    Sugrue JA; Bourke NM; O'Farrelly C
    Front Immunol; 2021; 12():757249. PubMed ID: 34917078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Type I interferon therapy and its role in autoimmunity.
    Biggioggero M; Gabbriellini L; Meroni PL
    Autoimmunity; 2010 Apr; 43(3):248-54. PubMed ID: 20298125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Type I interferon signature in systemic lupus erythematosus.
    Bezalel S; Guri KM; Elbirt D; Asher I; Sthoeger ZM
    Isr Med Assoc J; 2014 Apr; 16(4):246-9. PubMed ID: 24834763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Type I interferon as a target of treatment in SLE.
    Lee PY; Reeves WH
    Endocr Metab Immune Disord Drug Targets; 2006 Dec; 6(4):323-30. PubMed ID: 17214578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Type I interferon blockade in systemic lupus erythematosus: where do we stand?
    Lauwerys BR; Ducreux J; Houssiau FA
    Rheumatology (Oxford); 2014 Aug; 53(8):1369-76. PubMed ID: 24344319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RIG-I-like receptors and autoimmune diseases.
    Kato H; Fujita T
    Curr Opin Immunol; 2015 Dec; 37():40-5. PubMed ID: 26530735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting the interferon pathway with sifalimumab for the treatment of systemic lupus erythematosus.
    Greth W; Robbie GJ; Brohawn P; Hultquist M; Yao B
    Immunotherapy; 2017 Jan; 9(1):57-70. PubMed ID: 28000522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Type I interferon in systemic lupus erythematosus.
    Crow MK
    Curr Top Microbiol Immunol; 2007; 316():359-86. PubMed ID: 17969456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.